---
layout: post
title: HCV DAA Treatment Appeal Letters
date: 2016-09-13 10:00:00
---

[![](/assets/images/hcv-daa-treatment-appeal-letters.png)](http://hcvtreatmentaccess.org/drug-appeals/)

The template letters below are offered to help with challenging health plan coverage denials of Direct- Acting Antivirals Agents. The letters may be downloaded and modified for submission to health insurers.

Acknowledgements: Thank you to Kris Kowdley, MD with Swedish Medical Center for contributing the draft template letters.

[Denial Appeal - GT1 Naive 12 Wk Treatment With ViekiraPak and Riba for Cirrhotic INF Contraindicated Patient.docx](https://jumpshare.com/v/l0otHrl7fk0yXuGHBwQA)

[Denial Appeal - GT1 8-Week Sovaldi for INF Contraindicated Patient.docx](https://jumpshare.com/v/EsIJoP5ZJ5CNlf2I0nrO)

[Denial Appeal - GT1 Harvoni Re-Treate Post Sofosbuvir and Ribavirin Relapse.docx](https://jumpshare.com/v/eTrRuHiXLzWbXLaxwQY1)

[Denial Appeal - GT2 Re-Treat with Sovaldi and Riba Post INF-Riba Fail.docx](https://jumpshare.com/v/XIKuIbwQwmShPyBEy3X3)

[Denial Appeal - GT3 Naive 12 Wk Treatment With Daklinza-Sovaldi.docx](https://jumpshare.com/v/BQeoUDkuPYb7qEivW88S)

[Denial Appeal - Generic GT3 Naive 12 wks F0-2 DacSof.docx](https://jumpshare.com/v/2pqaxtzXjL9gqUsId1Xp)

[Denial Appeal - GT1 12-24-Week Harvoni and Riba for decompensated INF Contraindicated Patient.docx](https://jumpshare.com/v/S9Gg8e0jmcmx2rXWDQBW)

